Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections

NCT06537609 is registered in ClinicalTrials.gov with Sunnybrook Health Sciences Centre as lead sponsor.

NCT NCT06537609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06537609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections
Lead sponsor
Sunnybrook Health Sciences Centre
Phase
Not applicable
Overall status
Recruiting
Start date
April 24, 2024
Completion date
April 30, 2028
Enrollment
2,500 (estimated)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

gram-negative bacteremia